Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

Nanocarriers can improve the effectiveness of herbal medicines in treating colorectal cancer.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.

Skin reactions from cancer treatments might predict how well the treatments work.

Ozone therapy might improve cancer treatment and reduce its side effects.

FDG PET/CT scans can change cancer treatment plans for dogs.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Aromatase inhibitors cause male pattern hair loss in women.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Targeting the Smoothened receptor shows promise for treating certain cancers.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.